In Ho Song

Dr. In Ho Song


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Nunzio DenoraNunzio Denora
Nunzio Denora
CLChaedong Lee
Chaedong Lee
Rosa Maria IacobazziRosa Maria Iacobazzi
Rosa Maria Iacobazzi
JCJi Young Choi
Ji Young Choi
ISIn Ho Song
In Ho Song
SKSang Eun Kim
Sang Eun Kim

29 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
YSYoo Sung Song
Yoo Sung Song
SLSang Hee Lee
Sang Hee Lee
JJJae Ho Jung
Jae Ho Jung
ISIn Ho Song
In Ho Song
HPHyun Soo Park
Hyun Soo Park
BLByung Chul Lee
Byung Chul Lee
We performed in vivo PET imaging with 3-[18F]F-CP118,954 (1) for acetylcholinesterase (AChE) and [18F]fluoromethyl-PBR28-d2 (2) for translocator protein 18-kDa (TSPO) to investigate the inflammatory brain response after stroke. Imaging studies were performed in the middle cerebral artery occlusion (MCAO) Sprague-Dawley rat model for a period of three weeks. The percentage injected dose per tissue weight (%ID/g) of striatum of 1, and cortex of 2 were obtained, respectively. To trace the sequential inflammatory responses, AChE imaging of 1 was done on post-MCAO day 2, after giving cold PK-11195 for 1 day, and TSPO imaging of 2 was carried out on post-MCAO day 11, after giving donepezil for 10 days. AChE activity in the MCAO-lesioned side were significantly higher than that of the contralateral side on day one, and TSPO activity was highest on day 11. TSPO inhibitor, PK-11195 did not affect AChE activity on day two, while AChE inhibitor, donepezil significantly lowered TSPO binding on day 12. Our study demonstrates that AChE level is elevated in the early course of brain ischemia as a trigger for the inflammatory response, and TSPO level is elevated persistently throughout the post-ischemic injury in the brain. Also, the AChE inhibitor may be able to inhibit or delay neurotoxic inflammatory responses and serve as a beneficial treatment option.